Biomarkers in Cancer has formally joined the Committee on Publishing Ethics.

COPE provides guidelines that are applied in situations such as where plagiarism allegations are made against a paper.  By becoming a COPE member there can be no doubt amongst authors of questionable papers that journals will apply commonly accepted industry-standard guidelines.  In more difficult cases Editors in Chief and Associate Editors will have access to COPE's advisory group.

Membership of COPE reflects our commitment to providing Biomarkers in Cancer readers and authors with highly professional and well organised scholarly publishing and research.

To read more visit the Biomarkers in Cancer Aims and Scope page